Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients

O. B. Holland, Von Kuhnert La Von Kuhnert, W. B. Campbell, R. J. Anderson

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Diuretics have been particularly successful for treatment of low-renin hypertension (LRH), although they may cause metabolic complications such as hypokalemia and hyperglycemia. Since the efficacy of diuretics is largely limited by reactive angiotensin II production, a combination of a converting enzyme inhibitor with a diuretic should be synergistic, particularly in LRH, where heightened aldosterone production in response to angiotensin II has been noted. Eighteen patients with LRH were treated initially with either captopril alone (450 mg/day) or hydrochlorothiazide (HCTZ) (up to 100 mg/day). Captopril alone only reduced average placebo standing blood pressure from 151/100 to 146/96 mm Hg. Combination of HCTZ with captopril reduced average standing blood pressure to 111/76 mm Hg at 3 months and 116/81 mm Hg at 1 year while allowing reductions in average captopril dosage to 100 mg/day and HCTZ-induced hyperglycemia. Captopril monotherapy did not increase urinary excretion of kallikrein, prostaglandin E2, or 6-keto prostaglandin F(1α), a metabolite of prostacyclin, and did not reduce urinary aldosterone excretion chronically. Thus, a synergism of captopril with HCTZ may be advantageous in certain patients with LRH.

Original languageEnglish
Pages (from-to)235-239
Number of pages5
JournalHypertension
Volume5
Issue number2 I
StatePublished - 1983

Fingerprint

Captopril
Renin
Diuretics
Hypertension
Hydrochlorothiazide
Aldosterone
Angiotensin II
Hyperglycemia
Blood Pressure
Tissue Kallikreins
Hypokalemia
Prostaglandins F
Enzyme Inhibitors
Epoprostenol
Therapeutics
Dinoprostone
Placebos
hydrochlorothiazide drug combination captopril

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Holland, O. B., La Von Kuhnert, V. K., Campbell, W. B., & Anderson, R. J. (1983). Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. Hypertension, 5(2 I), 235-239.

Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. / Holland, O. B.; La Von Kuhnert, Von Kuhnert; Campbell, W. B.; Anderson, R. J.

In: Hypertension, Vol. 5, No. 2 I, 1983, p. 235-239.

Research output: Contribution to journalArticle

Holland, OB, La Von Kuhnert, VK, Campbell, WB & Anderson, RJ 1983, 'Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients', Hypertension, vol. 5, no. 2 I, pp. 235-239.
Holland, O. B. ; La Von Kuhnert, Von Kuhnert ; Campbell, W. B. ; Anderson, R. J. / Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. In: Hypertension. 1983 ; Vol. 5, No. 2 I. pp. 235-239.
@article{f92e190ada0d4ae28b2d92eaf7c2472c,
title = "Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients",
abstract = "Diuretics have been particularly successful for treatment of low-renin hypertension (LRH), although they may cause metabolic complications such as hypokalemia and hyperglycemia. Since the efficacy of diuretics is largely limited by reactive angiotensin II production, a combination of a converting enzyme inhibitor with a diuretic should be synergistic, particularly in LRH, where heightened aldosterone production in response to angiotensin II has been noted. Eighteen patients with LRH were treated initially with either captopril alone (450 mg/day) or hydrochlorothiazide (HCTZ) (up to 100 mg/day). Captopril alone only reduced average placebo standing blood pressure from 151/100 to 146/96 mm Hg. Combination of HCTZ with captopril reduced average standing blood pressure to 111/76 mm Hg at 3 months and 116/81 mm Hg at 1 year while allowing reductions in average captopril dosage to 100 mg/day and HCTZ-induced hyperglycemia. Captopril monotherapy did not increase urinary excretion of kallikrein, prostaglandin E2, or 6-keto prostaglandin F(1α), a metabolite of prostacyclin, and did not reduce urinary aldosterone excretion chronically. Thus, a synergism of captopril with HCTZ may be advantageous in certain patients with LRH.",
author = "Holland, {O. B.} and {La Von Kuhnert}, {Von Kuhnert} and Campbell, {W. B.} and Anderson, {R. J.}",
year = "1983",
language = "English",
volume = "5",
pages = "235--239",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2 I",

}

TY - JOUR

T1 - Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients

AU - Holland, O. B.

AU - La Von Kuhnert, Von Kuhnert

AU - Campbell, W. B.

AU - Anderson, R. J.

PY - 1983

Y1 - 1983

N2 - Diuretics have been particularly successful for treatment of low-renin hypertension (LRH), although they may cause metabolic complications such as hypokalemia and hyperglycemia. Since the efficacy of diuretics is largely limited by reactive angiotensin II production, a combination of a converting enzyme inhibitor with a diuretic should be synergistic, particularly in LRH, where heightened aldosterone production in response to angiotensin II has been noted. Eighteen patients with LRH were treated initially with either captopril alone (450 mg/day) or hydrochlorothiazide (HCTZ) (up to 100 mg/day). Captopril alone only reduced average placebo standing blood pressure from 151/100 to 146/96 mm Hg. Combination of HCTZ with captopril reduced average standing blood pressure to 111/76 mm Hg at 3 months and 116/81 mm Hg at 1 year while allowing reductions in average captopril dosage to 100 mg/day and HCTZ-induced hyperglycemia. Captopril monotherapy did not increase urinary excretion of kallikrein, prostaglandin E2, or 6-keto prostaglandin F(1α), a metabolite of prostacyclin, and did not reduce urinary aldosterone excretion chronically. Thus, a synergism of captopril with HCTZ may be advantageous in certain patients with LRH.

AB - Diuretics have been particularly successful for treatment of low-renin hypertension (LRH), although they may cause metabolic complications such as hypokalemia and hyperglycemia. Since the efficacy of diuretics is largely limited by reactive angiotensin II production, a combination of a converting enzyme inhibitor with a diuretic should be synergistic, particularly in LRH, where heightened aldosterone production in response to angiotensin II has been noted. Eighteen patients with LRH were treated initially with either captopril alone (450 mg/day) or hydrochlorothiazide (HCTZ) (up to 100 mg/day). Captopril alone only reduced average placebo standing blood pressure from 151/100 to 146/96 mm Hg. Combination of HCTZ with captopril reduced average standing blood pressure to 111/76 mm Hg at 3 months and 116/81 mm Hg at 1 year while allowing reductions in average captopril dosage to 100 mg/day and HCTZ-induced hyperglycemia. Captopril monotherapy did not increase urinary excretion of kallikrein, prostaglandin E2, or 6-keto prostaglandin F(1α), a metabolite of prostacyclin, and did not reduce urinary aldosterone excretion chronically. Thus, a synergism of captopril with HCTZ may be advantageous in certain patients with LRH.

UR - http://www.scopus.com/inward/record.url?scp=0020660683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020660683&partnerID=8YFLogxK

M3 - Article

C2 - 6337951

AN - SCOPUS:0020660683

VL - 5

SP - 235

EP - 239

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2 I

ER -